Effects of inflammatory mediators on bone marrow mesenchymal stem cells

Despite osteoarthritis (OA) being the most prevalent form of joint disease, there is a striking unmet need for treatment strategies, with current treatments focused on the relief of pain symptoms. The inherent properties of mesenchymal stem cells (MSCs) make them an attractive candidate for a novel...

Full description

Bibliographic Details
Main Author: Marsh, Sarah A.
Format: Thesis (University of Nottingham only)
Language:English
Published: 2019
Subjects:
Online Access:https://eprints.nottingham.ac.uk/56737/
_version_ 1848799373006209024
author Marsh, Sarah A.
author_facet Marsh, Sarah A.
author_sort Marsh, Sarah A.
building Nottingham Research Data Repository
collection Online Access
description Despite osteoarthritis (OA) being the most prevalent form of joint disease, there is a striking unmet need for treatment strategies, with current treatments focused on the relief of pain symptoms. The inherent properties of mesenchymal stem cells (MSCs) make them an attractive candidate for a novel transplantation strategy, as they have both the potential to differentiate into chondrocytes for replacement of degraded cartilage, and the potential to exert immunosuppressive effects for modulation of the inflammatory environment. However, the inflammatory environment of the joint may affect the ability of these cells to functionally integrate into the host tissue and exert beneficial effects, as indicated by a lack of success seen in clinical trials. Identification of factors and cell signalling pathways that influence MSC function is therefore critical for ensuring their success in the clinic, and so this in vitro project aimed to identify the effects of inflammatory mediators on bone marrow MSCs (BMSCs). To investigate this, BMSCs were cultured in the presence of inflammatory mediators associated with OA pathology (IL-1β, IL-8, IL-10, MCP-1, NGF), either individually or in combination. Results showed that conditions containing IL-1β significantly affected the differentiation response of these cells under chondrogenic and osteogenic conditions. Gene expression analysis revealed changes in MAPK, Wnt and TLR signalling pathways, and highlighted the increased expression of pro-inflammatory cytokines and cartilage degrading enzymes. This work provides a basis for further investigation into factors present in the OA joint that may limit the therapeutic potential of MSCs, supporting further research into ways to circumvent this for novel OA treatments.
first_indexed 2025-11-14T20:34:38Z
format Thesis (University of Nottingham only)
id nottingham-56737
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:34:38Z
publishDate 2019
recordtype eprints
repository_type Digital Repository
spelling nottingham-567372025-02-28T14:31:31Z https://eprints.nottingham.ac.uk/56737/ Effects of inflammatory mediators on bone marrow mesenchymal stem cells Marsh, Sarah A. Despite osteoarthritis (OA) being the most prevalent form of joint disease, there is a striking unmet need for treatment strategies, with current treatments focused on the relief of pain symptoms. The inherent properties of mesenchymal stem cells (MSCs) make them an attractive candidate for a novel transplantation strategy, as they have both the potential to differentiate into chondrocytes for replacement of degraded cartilage, and the potential to exert immunosuppressive effects for modulation of the inflammatory environment. However, the inflammatory environment of the joint may affect the ability of these cells to functionally integrate into the host tissue and exert beneficial effects, as indicated by a lack of success seen in clinical trials. Identification of factors and cell signalling pathways that influence MSC function is therefore critical for ensuring their success in the clinic, and so this in vitro project aimed to identify the effects of inflammatory mediators on bone marrow MSCs (BMSCs). To investigate this, BMSCs were cultured in the presence of inflammatory mediators associated with OA pathology (IL-1β, IL-8, IL-10, MCP-1, NGF), either individually or in combination. Results showed that conditions containing IL-1β significantly affected the differentiation response of these cells under chondrogenic and osteogenic conditions. Gene expression analysis revealed changes in MAPK, Wnt and TLR signalling pathways, and highlighted the increased expression of pro-inflammatory cytokines and cartilage degrading enzymes. This work provides a basis for further investigation into factors present in the OA joint that may limit the therapeutic potential of MSCs, supporting further research into ways to circumvent this for novel OA treatments. 2019-07-19 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/56737/1/Sarah%20Marsh%20Corrected%20PhD%20Thesis.pdf Marsh, Sarah A. (2019) Effects of inflammatory mediators on bone marrow mesenchymal stem cells. PhD thesis, University of Nottingham. Osteoarthritis Mesenchymal stem cells Inflammation Chondrogenesis Osteogenesis
spellingShingle Osteoarthritis
Mesenchymal stem cells
Inflammation
Chondrogenesis
Osteogenesis
Marsh, Sarah A.
Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title_full Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title_fullStr Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title_full_unstemmed Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title_short Effects of inflammatory mediators on bone marrow mesenchymal stem cells
title_sort effects of inflammatory mediators on bone marrow mesenchymal stem cells
topic Osteoarthritis
Mesenchymal stem cells
Inflammation
Chondrogenesis
Osteogenesis
url https://eprints.nottingham.ac.uk/56737/